Aprepitant quetiapine: a clinically significant drug interaction in a patient treated for head and neck cancer.
Departments of General Internal Medicine. Electronic address: m.hoeks@aig.umcn.nl.
M P A
MPA
Verwimp-Hoeks
Departments of Oncology.
C M L
CML
van Herpen
Departments of Pharmacy, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
D M
DM
Burger
D000328:Adult; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism; D000932:Antiemetics / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism; D000970:Antineoplastic Agents / Q000008:administration & dosage; D000077608:Aprepitant; D002277:Carcinoma / Q000188:drug therapy*; D059248:Chemoradiotherapy; D002945:Cisplatin / Q000008:administration & dosage; D015283:Citalopram / Q000008:administration & dosage; D003863:Depression / Q000188:drug therapy; D003907:Dexamethasone / Q000008:administration & dosage; D003987:Dibenzothiazepines / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism; D004347:Drug Interactions; D006801:Humans; D007822:Laryngeal Neoplasms / Q000188:drug therapy*; D008297:Male; D009025:Morpholines / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism; D017294:Ondansetron / Q000008:administration & dosage; D000069348:Quetiapine Fumarate
D000928:Antidepressive Agents; D000932:Antiemetics; D000970:Antineoplastic Agents; D003987:Dibenzothiazepines; D009025:Morpholines; D015283:Citalopram; D000077608:Aprepitant; D000069348:Quetiapine Fumarate; D017294:Ondansetron; D003907:Dexamethasone; D002945:Cisplatin